4//SEC Filing
Howe Jolanda 4
Accession 0001415889-25-002980
CIK 0001759425other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:30 PM ET
Size
8.9 KB
Accession
0001415889-25-002980
Insider Transaction Report
Form 4
Howe Jolanda
SVP, GLOBAL CONTROLLER
Transactions
- Exercise/Conversion
Common Stock
2025-01-31+1,772→ 5,296 total - Sale
Common Stock
2025-02-03$48.22/sh−1,064$51,309→ 4,232 total - Exercise/Conversion
Restricted Stock Units
2025-01-31−1,772→ 1,771 total→ Common Stock (1,772 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001974200
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:30 PM ET
- Size
- 8.9 KB